Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Little Green Pharma Ltd. ( (AU:LGP) ) is now available.
Little Green Pharma Ltd announced the retirement of Director David Fenlon due to personal reasons and other commitments. As a result, the company has withdrawn resolutions related to his election and the approval of retention rights, ensuring that other business items at the AGM remain unaffected. This decision reflects the company’s adaptability and focus on maintaining its operational integrity and stakeholder interests.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd (ASX:LGP) is a leading global medicinal cannabis company with vertically integrated operations across Europe and Australia. The company offers a diverse portfolio of cannabis-based medicines distributed across Australia and over 12 export markets. It operates three production facilities in Denmark and Australia, positioning itself as a key player in global medicinal cannabis markets.
Average Trading Volume: 134,254
Technical Sentiment Signal: Buy
Current Market Cap: A$35.06M
See more insights into LGP stock on TipRanks’ Stock Analysis page.